Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene therapy expertise, today announced the significant expansion of its gene therapy platform.

What is unfolding now is not merely a tactical disagreement over Yemen, but an expression of deeper strategic, economic, and ...

The second, perhaps somewhat less appreciated but no less significant, is the Supreme Court’s ascent—its expansion of its ...

Portugal's growth is projected to outpace the eurozone average once again. Since the end of 2019, the country's growth has ...

The capture of Nicolás Maduro created a tactical opening but has not yet produced a strategic shift in Venezuela’s political ...

The US sovereign wealth fund (SWF) announced in early 2025 is not a symbolic policy experiment or a passive reserve vehicle.

Corporate profit margins are holding firm, and gains in household wealth are sustaining consumer spending despite labor ...

Most HR systems aren’t built to address impostor syndrome. They recognize burnout but not the cognitive load of chronic ...

Bitcoin's market cap ratio to gold shows R² 0.959 correlation since 2010, projecting potential parity with gold's $16T by mid ...

The results of 2025 indicate that Russia's industry has shifted into stagnation following a brief period of growth driven by ...

The government’s tax reforms will increase the disposable income of consumers while measures such as the Labour Codes will ...

Gilles de Greling, Palm Beach Director of Gander & White, analyzes how philanthropy has evolved from episodic generosity into ...